WebOverview Fingerprint Abstract Background: Carboplatin-etoposide (CarboEtop) is a 1st-line option for patients with advanced extra-pulmonary (EP), poorly-differentiated (PD) neuroendocrine carcinoma (NEC). Different schedules are used in clinical practice and randomised evidence is lacking. WebDescriptions. Carboplatin belongs to the group of medicines known as alkylating agents. It is used to treat cancer of the ovaries. It may also be used to treat other kinds of cancer, …
Etoposide phosphate with carboplatin in the treatment of …
WebJul 11, 2024 · The carboplatin/etoposide combination has demonstrated a better toxicity profile compared to cisplatin/etoposide and is much better tolerated in the elderly population. [4] When using etoposide in combination with other chemotherapeutic agents against testicular cancer, response rates of about 80% have been observed in patients. [5] WebMay 20, 2010 · Conclusions: Carboplatin/etoposide combination is active and well-tolerated in patients with aggressive extra-pulmonary NECs. Therefore carboplatin could be considered as an alternative when some cisplatin toxicity should be avoided. Furthermore, based on these results a prospective head-to-head carboplatin/cisplatin comparison is … ps waimarie
Efficacy and Safety of Carboplatin and Etoposide Combination ...
WebNov 17, 2024 · Carboplatin is a chemotherapy drug that attaches to deoxyribonucleic acid (DNA) and may kill tumor cells. Giving entinostat in combination with atezolizumab, carboplatin and etoposide may work better than atezolizumab, carboplatin and etoposide alone. WebJan 17, 2024 · Carboplatin/Etoposide 4-7,b. Day 1: Carboplatin AUC 5–6 IV over 30 minutes, followed by: Days 1–3: Etoposide 100mg/m 2 IV over 60 minutes daily. Repeat … WebMar 30, 2024 · We conducted an investigator initiated, single-center, open-label, prospective phase 1 study evaluating the safety and efficacy of CFZ in combination with rituximab, ifosfamide, carboplatin, and etoposide (C-R-ICE) in high-dose chemotherapy with autologous stem cell transplant (HDC-ASCT) eligible patients with R/R DLBCL … horse events swalcliffe